Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer

NCT03114462 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Malignant Neoplasms of Respiratory and Intrathoracic Organs
Squamous Cell Carcinoma of the Larynx

Interventions

RADIATION: Stereotactic Hypofractionated Radioablation
BEHAVIORAL: Questionnaires

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]